Article info
PDFShort report
Dexamethasone-free antiemetic strategy for highly emetogenic chemotherapy: safety and efficacy-pilot study
- Correspondence to Dr Vinod Sharma, Department of Medical Oncology, National Cancer Institute, Jhajjar, Haryana, India; vinod_mbbs4u{at}yahoo.co.in
Citation
Dexamethasone-free antiemetic strategy for highly emetogenic chemotherapy: safety and efficacy-pilot study
Publication history
- Received July 12, 2022
- Accepted February 28, 2023
- First published March 16, 2023.
Online issue publication
January 11, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.